(Total Views: 209)
Posted On: 03/11/2019 9:52:21 AM
Post# of 155053
In reading this again, it seems like an old PR that was not released when initially drafted. My reasoning for this it states "after 7 weeks" and "Leronlimab (PRO 140) has successfully completed seven Phase 1/2/3 clinical trials in over 670 people"....both of which would be more aligned with late February data.
The "6 week" PR was released on 20 Feb 2019 and the 4 Mar PR states "in over 700 people"
20 Feb PR: https://www.cytodyn.com/media/press-releases/...man-breast
4 Mar PR: https://www.cytodyn.com/media/press-releases/...ed-bla-for
11 Mar PR: https://www.cytodyn.com/media/press-releases/...ast-cancer
The "6 week" PR was released on 20 Feb 2019 and the 4 Mar PR states "in over 700 people"
20 Feb PR: https://www.cytodyn.com/media/press-releases/...man-breast
4 Mar PR: https://www.cytodyn.com/media/press-releases/...ed-bla-for
11 Mar PR: https://www.cytodyn.com/media/press-releases/...ast-cancer
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
